Several membrane oxygenators for use during routine cardiopulmonary bypass have been available over the past ten years. These have included the Lande-Edwards, Travenol Teflo and the Kolobow spiral coil membrane oxygenators. Each has had disadvantages. Poor gas transfer efficiency, the need for a twopump circuit, and complex setting-up procedures have all contributed to making a membrane oxygenator cumbersome for everyday use. In addition it has not been shown that membrane oxygenators offer any advantage in short perfusions, even though in vitro they produce less destruction of blood components and fewer particulate emboli. 1, 2 Recently a new membrane oxygenator, the Terumo Capiox hollow-fibre oxygenator, has become available, and this paper describes the clinical use of this oxygenator during routine coronary artery bypass graft surgery.
The Capiox membrane oxygenator (Figure 1 ) consists of a very large number of hollow fibres made of polypropylene. Each fibre has an internal diameter of 200 micrometres and a wall thickness of 25 micrometres. There are pores of 0.07 micrometres diameter in the fibre wall. The fibres are arranged parallel to each other and blood passes within the fibres, and gas surrounds the outside of the fibres. The manufacturers state that a pressure in excess of 1000 mmHg is required to cause fluid to cross into the gas phase. There is an integral heat exchanger beneath the oxygenating column. It consists of thin-walled, parallel, stainless-steel tubes. The oxygenator casing is made of Acrylo Nitrile-Styrene Copolymer. There are four sizes of oxygenator available -1.6, 3.3,4.3 and 5.4 square metres. We tested the 4.3 square metre device which is recommended for patients weighing between 60-90 kilograms. This oxygenator is cylindrical and measures 29 cm in length and 13 cm in diameter and has a priming volume of 550 m!. A distensible polyvinylchloride venous reservoir (one litre) is mounted at the same level as the oxygenator (Figure 2 ).
METHOD
Ten adult patients underwent coronary artery bypass grafting using a Capiox 4.3 square metre oxygenator. The bypass circuit was primed with crystalloid solution 1000 ml and stable plasma protein solution (SPPS) 500 m!. The patient was heparinised to achieve an activated clotting time in excess of 400 seconds, and the ascending aorta cannulated with a 7 mm internal diameter cannula. Blood was collected from this cannula for plasma-free haemoglobin estimation. Venous drainage was through a single right atrial cannula. Non-pulsatile flow with a undertaken by using water at 5 QC flowing at 14 litres per minute through an integral heat exchanger. For rewarming, water at 42 QC was used but adjusted so that arterial blood temperature did not exceed 38 QC. We used the smallest gas flow that we considered would achieve an arterial oxygen tension between 100-250 mmHg, and a carbon dioxide tension of 35-45 mmHg. The blood gas results were corrected for temperature. Blood gas samples were taken after five minutes at 37 QC, after ten minutes at 28 QC, and after ten minutes at 36 QC (after rewarming). Platelet counts were done after the cardioplegia had been infused, at the end of bypass, and on the first postoperative day. Plasma-free haemoglobin estimations were made at c~nnulation of the aorta and at the end of bypass.
RESULTS
Patients' weights and bypass parameters can be seen in Table 1 .
Gas transfer results are seen in Table 2 . We sometimes achieved higher oxygen tensions than desired and during rewarming the average PC02 was higher than we wanted. The mean pressur.e gradient across the membrane was 74 (SD 34, range 23-135) mmHg. Hypothermia was achieved in an average of 9.1 (SD 3.1, range 5-15) minutes, and rewarming in 15.1 (SD 3.1, range 10-20) minutes. Platelet counts and plasma-free haemoglobin levels are shown in Table 3 .
DISCUSSION
This oxygenator was satisfactory for routine clinical use. It is compact and can be mounted with little variation from standard perfusion circuits. It was readily positioned so that an adequate height between the patient and the oxygenator could be achieved at normal operating table heights. Priming and debubbling the oxygenator was not difficult, and no previous flushing with carbon dioxide was necessary. This is an advantage over the Kolobow spiral coil membrane. The oxygenator is placed on the arterial side of the bypass circuit, which eliminates the stasis possible with oxygenators positioned on the venous side. In this situation we consider the use of an arterial line filter advisable. The resistance provided by the oxygenator was low and did not approach the pressure of 1000 mmHg (manufacturer's figure) where fluid transudation might occur. This low resistance eliminates the need for a second pump which is the principal disadvantage of the Travenol Teflo membrane oxygenator .
Oxygen transfer was extremely efficient, and as the study proceeded we used progressively lower total gas flows in relation to total blood flow. Even then the arterial oxygen tensions were greater than we wanted. This progressively lower total gas flow using between 97-100070 oxygen did, however, cause ail increase in arterial carbon dioxide tensions during rewarming . We consider that to keep the arterial P0 2 low enough and also to eliminate carbon dioxide, a higher total gas flow using air and oxygen mixture would be appropriate. Even in patients whose weight was near the upper limits recommended for the 4.3 square metre oxygenator, there appeared to be adequate reserves of gas transfer capability. Heat exchanger performance was good and comparable with that available in bubble oxygenators. This is certainly important with valve replacements and with the increasingly popular sequential coronary artery grafts, where the number of proximal aortic anastomoses is small. In these situations the time between removal of the aortic cross-clamp and cessation of bypass is short.
We used the oxygenator for bypass graft operations where cardiotomy suction is less than for open-heart procedures. However, as previously described, extensive pericardial suction is undertaken by this unit. 3 The plasmafree haemoglobin levels were considerably lower than for bubble oxygenators we previously studied, although the average bypass time was a little shorter in this study. 4 Platelet counts at various stages of the operative and postoperative period were adequate for haemostasis, even with the haemodilution that occurred.
In summary, we found the Capiox 4.3 square metre oxygenator to be efficient and convenient for clinical use. In our opinion it is the best of the available membrane oxygenators for routine clinical use. In addition its price is comparable with "hard-shell" bubble oxygenators. 
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